Active substanceTroxerutinTroxerutin
Similar drugsTo uncover
  • Troxevasin®
    gel externally 
    AKTAVIS, LTD.     Russia
  • Troxevasin®
    capsules inwards 
  • Troxsevenol
    gel externally 
    SAMARAHEDPROM, JSC     Russia
  • Troxerutin
    gel externally 
  • Troxerutin
    capsules inwards 
    ATOLL, LLC     Russia
  • Troxerutin
    gel externally 
    ATOLL, LLC     Russia
  • Troxerutin
    capsules inwards 
    SYNTHESIS, OJSC     Russia
  • Troxerutin
    gel externally 
  • Troxerutin
    gel externally 
    GREEN DUBRAVA, CJSC     Russia
  • Troxerutin
    gel externally 
    VERTEKS, AO     Russia
  • Troxerutin
    capsules inwards 
    VERTEKS, AO     Russia
  • Troxerutin VetProm
    gel externally 
    VetProm AD     Bulgaria
  • Troxerutin Vramed
    capsules inwards 
    Sopharma, AO     Bulgaria
  • Troxerutin Vramed
    gel externally 
    Sopharma, AO     Bulgaria
  • Troxerutin Zentiva
    capsules inwards 
    Zentiva c.s.     Czech Republic
  • Troxerutin-MIC
    capsules inwards 
    MINSKINTERKAPS, UP     Republic of Belarus
  • Phlebopress®
    capsules inwards 
    ATOLL, LLC     Russia
  • Dosage form: & nbspgel for external use
    Composition:

    Composition: (per 100 g):

    Active substance: Troxerutin - 2.0 g;

    Excipients: carbomer 940 - 0.6 g, disodium edetate - 0.05 g, benzalkonium chloride - 0.1 g, sodium hydroxide solution 30 % - 0.7 g, purified water - 96.55 g

    Description:transparent, homogeneous gel from yellow to greenish-yellow
    Pharmacotherapeutic group:venotonic and venoprotective agent
    ATX: & nbsp

    C.05.C.A   Bioflavonoids

    C.05.C.A.04   Troxerutin

    Pharmacodynamics:

    Flavonoid (derivative of routine), has P-vitamin activity; has venotonic, angioprotective, anti-edematous, antioxidant and anti-inflammatory effects.

    It participates in oxidation-reduction processes, blocks hyaluronidase, stabilizes hyaluronic acid of cell membranes and reduces the permeability and fragility of capillaries, increases their tone. Increases the density of the vascular wall, reduces exudation of the liquid part of the plasma and diapedesis of blood cells.

    Reduces inflammation in the vascular wall, limiting the adhesion to its surface of platelets. Patients with chronic venous insufficiency are recommended to use both in the initial and late stages of the disease. In conditions characterized by increased vascular permeability (including scarlet fever, influenza, measles, allergic reactions), it is used in combination with ascorbic acid to enhance its effect.Non-toxic, has a large breadth of therapeutic effect.

    Pharmacokinetics:

    When gel is applied to the skin, the active component of the gel quickly penetrates the epidermis, after 30 minutes it is found in the dermis, and after 2-5 hours in the subcutaneous fatty tissue.

    Indications:

    Varicose veins, chronic venous insufficiency, accompanied by swelling, pain, sensation of heaviness in the legs; thrombophlebitis, periphlebitis, varicose dermatitis, pain and swelling after injuries (bruises, ligament injuries).

    Contraindications:

    Hypersensitivity, damage to the integrity of the skin, children under 15 years.

    Carefully:

    Renal failure (prolonged use).

    Pregnancy and lactation:

    Reception of the drug Troxerutin contraindicated in the first trimester of pregnancy. The drug can be used in the second and third trimester of pregnancy, as well as during lactation.

    Dosing and Administration:

    Outer: the gel is applied evenly in a thin layer in the morning and evening on the skin above the painful patch and gently massaged until completely absorbed. The dose of the drug depends on the area of ​​the damaged surface, but should not exceed 3-4 cm of gel (1.5-2 g).The gel can be applied under the occlusive dressing.

    Side effects:In some cases, allergic reactions are possible (skin rash).
    Interaction:

    There is no evidence of unfavorable interaction of troxerutin in the form of a gel with other drugs.

    Effect on the ability to drive transp. cf. and fur:Negative effect of the drug on the performance of potentially hazardous activities requiring special attention and quick reactions (driving, other vehicles, working with driving mechanisms, dispatcher and operator work, etc.) was not observed.
    Form release / dosage:Gel for external use.
    Packaging:

    25 g is placed in aluminum tubes. 25 g is placed in a jar of orange glass with a triangular corolla type BTS, ukuporennuyu cover lid with a sealing element. Each jar or tube together with the instruction for use is placed in a bundle. 20 cans, together with an equal number of instructions for medical use, are placed in boxes of cardboard for consumer containers.

    Storage conditions:

    In dry, protected from light and out of reach of children at a temperature of no higher than 25 ° C.

    Shelf life:

    5 years.Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:PL-000757
    Date of registration:29.09.2011
    The owner of the registration certificate:Promomed Rus, Open CompanyPromomed Rus, Open Company Russia
    Manufacturer: & nbsp
    Information update date: & nbsp21.10.2015
    Illustrated instructions
      Instructions
      Up